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ABSTRACT
Conversion of the primary bile acids cholic acid (CA) and chenodeoxycholic acid (CDCA) to the secondary bile acids deoxy-
cholic acid (DCA) and lithocholic acid (LCA) is performed by a few species of intestinal bacteria in the genus Clostridium
through a multistep biochemical pathway that removes a 7a-hydroxyl group. The rate-determining enzyme in this pathway
is bile acid 7a-dehydratase (baiE). In this study, crystal structures of apo-BaiE and its putative product-bound [3-oxo-D4,6-
lithocholyl-Coenzyme A (CoA)] complex are reported. BaiE is a trimer with a twisted a1 b barrel fold with similarity to
the Nuclear Transport Factor 2 (NTF2) superfamily. Tyr30, Asp35, and His83 form a catalytic triad that is conserved across
this family. Site-directed mutagenesis of BaiE from Clostridium scindens VPI 12708 confirm that these residues are essential
for catalysis and also the importance of other conserved residues, Tyr54 and Arg146, which are involved in substrate binding
and affect catalytic turnover. Steady-state kinetic studies reveal that the BaiE homologs are able to turn over 3-oxo-D4-bile
acid and CoA-conjugated 3-oxo-D4-bile acid substrates with comparable efficiency questioning the role of CoA-conjugation
in the bile acid metabolism pathway.
Proteins 2016; 00:000–000.
VC 2015 Wiley Periodicals, Inc.
Key words: gut microbes; secondary bile acid synthesis; gut microbe mediated human metabolite; 7a-dehyroxylation; bile acid
7a-dehydratase; primary bile acid; secondary bile acid; nuclear transport factor-2 superfamily; structural genomics.
INTRODUCTION
The human gut microbiome is a key aspect of normal
physiology and metabolic homeostasis. A large number
of normal host functions and disease states have been
associated with intestinal microbiota.1–5 Understanding
the interplay between host and microbe is a pivotal chal-
lenge since the underlying biochemical events are unde-
fined. Metabolomics studies performed with germ-free
Abbreviations: CoA, coenzyme A; IBD, inflammatory bowel disease; LCA, lithocholic acid; NTF2, nuclear transport factor 2; 3-oxo-D4-CDCA, 3-oxo-D4-che-
nodeoxycholate; 3-oxo-D4,6-LCA, 3-oxo-D4,6-lithocholate; 3-oxo-D4-CDC-CoA, 3-oxo-D4-chenodeoxycholyl coenzyme A; 3-oxo-D4,6-LC-CoA, 3-oxo-D4,6-lithocholyl
coenzyme A; TEV, tobacco etch virus
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and conventional mice have identified metabolites
processed by microbes, which can influence human
health.6–8 Among such metabolites, secondary bile acids,
deoxycholate (DCA) and lithocholate (LCA), which are
synthesized from primary bile acids cholate and cheno-
deoxycholate, respectively, are associated with an increase
in the incidence of cancers of the colon, esophagus, and
biliary track as well as cholesterol gallstone disease in
some patients.9–12 Furthermore, recent studies of
obesity-associated hepatocellular carcinoma (HCC) in
mice, implicated DCA with increased secretion of various
inflammatory and tumor promoting factors in the
liver.13 This study showed that blocking DCA produc-
tion could prevent HCC in obese mice.
Bile acids also act as hormones via activating specific
nuclear receptors (FXR, PXR, and vitamin D receptor)
and plasma membrane G-protein coupled receptors
[TGR-5, sphingosine-1-phosphate receptor 2, muscarinic
M (2) receptor] in a physiologically relevant manner.
Secondary bile acids are more powerful than primary
bile acids as activators of PXR, Vitamin D receptor, and
TGR-5 in cell signaling pathways.14 In humans, unlike
rodents, DCA can accumulate to very high levels
(>60%) in the bile acid pool as the human liver is
unable to hydroxylate DCA at the 7a-position.15 There-
fore, by controlling the composition of the bile acid
pool, specific gut bacteria may influence aspects of host
physiology and influence pathophysiology. Hence, the
microbial enzymes involved in secondary bile acid syn-
thesis are potential drug targets for human disease.
Microbial synthesis of secondary bile acids in the
human gut involves a multistep biochemical process that
results in the removal of C7-hydroxy group from pri-
mary bile acids (Fig. 1). This pathway, which is split into
oxidative and reductive arms, involves a series of
enzymes that are encoded by a bile acid inducible (bai)
operon.15 The pathway is initiated by the uptake of pri-
mary bile acid via a H1-dependent active transporter
(BaiG)16 followed by thioesterification to coenzyme A
(CoA) by a CoA-ligase (BaiB).17 The oxidative arm of
the pathway converts bile acid-CoA thioester to 3-oxo-
7a-hydroxy bile acid-CoA and 3-oxo-D427a-hydroxy
bile acid-CoA intermediates by BaiA18 and BaiCD,19
respectively. The 7a-hydroxy group is removed from the
latter through release of water by bile acid 7a dehydra-
tase, BaiE, yielding a 3-oxo-D4,6-bile acid-CoA intermedi-
ate.20 The subsequent three reductive steps catalyzed by
yet unidentified enzymes constitute the reductive arm
generating the secondary bile acid. Two CoA transferases,
BaiF and BaiK, participate in the removal of the CoA
moiety, although it remains unclear at which stage in the
pathway this occurs.21 Despite the significant influence
of this pathway on human health and disease, limited
structural and biochemical information is available for
the key microbial enzymes involved. We recently
reported the structural and steady-state kinetic character-
ization of BaiA2 from Clostridium scindens VPI 12708,
which represents the first structure–function characteri-
zation of enzymes in this pathway.22
Here we report the structural and biochemical charac-
terization of BaiE homologs from Clostridium sp. a key
human gut microbe associated with secondary bile acid
synthesis. The 7a-dehydroxylation step catalyzed by BaiE
is rate limiting for this pathway and is the only irreversi-
ble step that directs the intermediate from the oxidative
arm to the reductive arm generating the secondary bile
acid. BaiE has less than 30% sequence identity with its
nearest structural homolog. The BaiE crystal structure
reveals a canonical twisted a1b barrel fold that is also
observed in the Nuclear Transport Factor 2 (NTF2) fam-
ily. Structure-guided site directed mutagenesis studies
were carried out to identify and differentiate residues
involved in substrate binding versus those specifically
involved in catalysis. Furthermore, comparison of the co-
crystal structure of BaiE from Clostridium hiranonis
DSM13275 with the partially bound product [3-oxo-
D4,6-Lithocholyl Coenzyme A (3-oxo-D4,6-LC-CoA)] with
apo-structures of BaiE homologs revealed a dramatically
different conformation of the loop formed by residues
48–63. This segment forms the roof of the active site
pocket and suggests conformational flexibility may be
needed for substrate binding. Site-directed mutagenesis
of Tyr54 indicated impaired substrate turnover indicating
the importance of this loop in catalysis. A mechanism
for bile acid dehydratase catalysis is proposed based on
structural features and site-directed mutagenesis studies.
The insight from these structures should facilitate the
design of inhibitors which could modulate levels of sec-
ondary bile acids in pathways associated with human
health and disease.
MATERIALS ANDMETHODS
Gene cloning and site-directed mutagenesis
Genes of the BaiE homologs were cloned from the
corresponding genomic DNAs of C. scindens VPI12708,
C. scindens ATCC35704, C. hylemonae DSM15053, and
C. hiranonis DSM13275 by Polymerase Incomplete Primer
Extension (PIPE) cloning method.23,24 C. scindens
VPI12708 genomic DNA was isolated from anaerobically
grown culture.25 All other genomic DNAs were obtained
from the DSMZ (Braunschweig, Germany). The genes
were amplified by polymerase chain reaction (PCR) and
cloned into the expression vector, pSpeedET, which also
encodes an N-terminal tobacco etch virus (TEV) protease-
cleavable expression and purification (MGSDKIHHHHH-
HENLYFQ/G). Expression clones for PDB ID: 4L8P,
4LEH, 4L8O, and 4N3V are available from the NIH PSI
Materials Repository (http://psimr.asu.edu/MRLinks.html)
Site-directed mutants were generated using the QuikChan-
geTM Site-Directed Mutagenesis Kit (Agilent Technologies,
S. Bhowmik et al.
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La Jolla, CA). The expression vector pSport1-19k contain-
ing the baiE sequence was used as a template.20
Protein expression and purification
Proteins utilized for structure determination and
kinetic studies were prepared as described previously.22
Briefly, recombinant protein was expressed at 378C by
induction of the arabinose promoter with L-arabinose
(0.13%) for 6 h in a 0.5 L culture and purified by single
step Ni-NTA chromatography on a 1.5 mL bed volume.
LC-MS and SDS-PAGE analysis were consistent with the
22 kDa predicted molecular mass of the BaiE monomer
with an N-terminal expression and purification tag. The
oligomeric profile was determined by analytical size
exclusion chromatography performed at room tempera-
ture on an Agilent HP1100 HPLC system utilizing a Sho-
dex 8 3 300 mm Protein KW-802.5 column in 20 mM
Figure 1
Proposed steps involved in synthesis of secondary bile acid in human gut anaerobe, Clostridium sp. The oxidative and reductive arms of the path-
way are enclosed within salmon and blue colored boxes, respectively. Enzymes with crystal structures solved using the JCSG pipeline are denoted in
blue.
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Tris pH 7.5, 200 mM NaCl, 0.5 mM TCEP, and 3 mM
NaN3. The N-terminal expression and purification tags
were not cleaved in this study. Selenomethionine (Se-
Met) derivatized proteins were utilized for structure
determination and native proteins were utilized for
kinetic studies and co-crystallization trials.
Synthesis of bile acid substrates and
products
CoA-thioesters of bile acids were prepared as described
previously.22 3-Oxo-D4-chenodeoxycholic acid (3-oxo-D4-
CDCA)26 and 3-oxo-D4,6-lithocholic acid (3-oxo-D4,6-
LCA)27 were synthesized following published procedures.
Commercially obtained chemicals used in the synthesis
were utilized without further purification or drying.
Steady-state kinetics
Steady-state kinetic parameters were determined using
a Varian Cary 100 Bio UV–Visible spectrophotometer
equipped with a thermo-jacketed cuvette holder. The
reactions at 258C in 20 mM Tris–HCl pH 7.3 monitored
the formation of the product at 297 nm. Reaction rates
were investigated under varying substrate concentrations
below and above the respective KM values. The initial lin-
ear regions of the reaction progress curves were utilized
for determining the reaction rates. The data were fitted
to the Michaelis–Menten equation by non-linear regres-
sion method using the enzyme kinetics module in
GraphPad Prism (GraphPad Software, La Jolla, CA).
Detection of substrate turnover by 1H-NMR
1H-NMR spectra were acquired at 3008K on a Bruker
Avance instrument equipped with a 1H/13C/15N-TXI cry-
oprobe operating at 600 MHz with 16 scans and a recycle
delay of 2 s employing excitation sculpting to suppress
water signal (Hwang and Shaka). Isotope-labeled com-
pounds were purchased from Sigma-Aldrich/Isotec. All
reaction samples contained 3-(trimethylsilyl)22,20,3,30-tet-
radeuteropropionic acid as an internal standard that was
referenced to 0 ppm and 10% D2O. The reaction was ini-
tiated by adding enzyme to an ice cold solution containing
100 mM substrate prepared in deuterated DMSO. Samples
were immediately transferred to the NMR instrument and
data collection initiated after temperature equilibration as
determined by the stability of the signal.
Substrate binding assay
Purified protein (100 lg) was suspended in 50 lL of
reaction mixture containing 25 mM sodium acetate pH
7.5 with 3-[N-morpholino]propanesulfonic acid (MOPS)
and bile acid substrate (18,000 dpm). The reaction was
incubated for 1 min at 378C in 10K Nanosep centrifugal
concentrators (Pall Filtron). The concentrators were cen-
trifuged at 10,000g for 2 min. Samples were washed with
an additional 100 lL of reaction buffer and centrifuged
again for 2 min. Bound counts and effluents were quan-
tified by liquid scintillation spectrometry. Bound counts
were corrected for non-specific binding against assays
with heat-denatured protein and background binding to
the filter.
Crystallization of BaiE
Selenomethionine derivatized BaiE protein from C.
scindens ATCC35704, and C. hiranonis DSM13275
yielded crystals from the JCSG Core Suite (Qiagen Scien-
ces, MD), conditions I-D8 (20% w/v PEG3350, 0.2M
sodium sulfate, pH 6.6; space group P3121), and IV-D4
(50% w/v PEG200, 0.1M HEPES pH 7.5; space group
P63), respectively. Standard JCSG protocols were utilized
for all crystallization trials28,29 using a drop volume of
0.2 mL and a 1:1 (vol/vol) ratio of reservoir to protein
(18.6 mg/mL, C. scindens ATCC35704 and 20.6 mg/mL
C. hiranonis DSM13275) in 20 mM HEPES pH 8.0 solu-
tion equilibrated against 100 mL of reservoir solution.
The crystals were cryoprotected with addition of 10% 1,2
ethanediol (C. scindens ATCC35704) or 10% glycerol (C.
hiranonis DSM13275) before harvesting and flash freez-
ing with liquid nitrogen. Co-crystallization trials involv-
ing native preparations of the proteins were performed
similarly with addition of 1 mM product, 3-oxo-D4,6-
Lithocholyl-Coenzyme A (3-oxo-D4,6-LC-CoA). Partial
binding of the product (see below) was observed in only
one co-crystal of C. hiranonis DSM13275 (space group
R32:h) obtained at a protein concentration of 21 mg/mL
from JCSG Core Suite condition I-G5 (10% PEG6000,
0.1M citric acid pH 5.0). This crystal was cryoprotected
with 15% 1,2-ethanediol. BaiE from C. hylemonae
DSM15053 (8.5 mg/mL) yielded crystals [JCSG Core
Suite condition III-E2 (0.01M cobalt chloride, 1.8M
ammonium sulfate, 0.1M MES pH 6.5; space group
R32:h)], but no ordered binding of the product was
observed in the structure. Prior to harvesting, 10% etha-
nediol was added to the drop.
Structure determination of BaiE
Experimental phases for BaiE homologs from C. scin-
dens and C. hiranonis were generated by multiple-
wavelength anomalous diffraction (MAD) and single-
wavelength anomalous diffraction (SAD) methods,
respectively. The X-ray diffraction data were collected at
wavelengths corresponding to the peak (k1), inflection
(k2), and high-energy remote (k3) wavelengths of sele-
nium for the MAD experiments and at the peak wave-
length of selenium for the SAD experiments. The data
were collected on beamline 11–1 at Stanford Synchrotron
Radiation Lightsource at 100 K with a Rayonix Mar
Mosaic MX-325 CCD detector using the Blu-Ice data-
collection environment.30 MOSFLM31 and SCALA32
S. Bhowmik et al.
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were used for data integrating and scaling. Selenium
positions were determined with SHELXD and the phases
were refined using autoSHARP,33 with a mean figure of
merit of 0.50–2.9 A˚ in space group P3121 for C. scindens
ATCC 35704 and 0.28–1.6 A˚ in space group P63 for C.
hiranonis DSM 13275. Automated model building was
performed with ARP/wARP.34 Data for the crystals
grown from the co-crystallization trials were collected on
beamline 8.2.2 at the Advanced Light Source with an
ADSC Q315 CCD detector at 100 K. The data were
reduced with XDS35 and scaled with XSCALE.36 The
structure of BaiE, C. hiranonis DSM13275 was used as a
search model for phasing the native BaiE from C. hyle-
monae DSM15053 and BaiE from C. hiranonis
DSM13275 structures originating from the co-
crystallization trials. Model completion and iterative
cycles of refinement were performed with COOT37 and
REFMAC38 from the CCP4 program suite.39 The TLS
refinement protocol included one TLS group per mole-
cule in the asu. Coordinates for 3-oxo-D4,6-LC-CoA,
polyethylene glycol (PEG) and ethylene glycol were gen-
erated using PRODRG.40 The library files containing the
refinement restraints were generated using LIBCHECK
within CCP4. The quality of the crystal structure was
analyzed using the JCSG Quality Control server (http://
smb.slac.stanford.edu/jcsg/QC). This server verifies: the
stereochemical quality of the model using AutoDepIn-
putTool,41 MolProbity,42 and Phenix,43 the agreement
between the atomic model and the data using
RESOLVE,44 the protein sequence using CLUSTALW,45
the ADP distribution using Phenix, and differences in
Rcryst/Rfree, expected Rfree/Rcryst, and various other items
including atom occupancies, consistency of NCS pairs,
ligand interactions and special positions using in-house
scripts to analyze refinement log file and PDB header.
Data collection, model, and refinement statistics are
summarized in Table I. Coordinates and the associated
structure factors are deposited in the Protein Data Bank
(PDB) with following accession codes: 4L8P—BaiE from
C. hiranonis DSM 13275; 4L8O—BaiE from C. hylemo-
nae DSM 15053; 4LEH—C. scindens ATCC 35704;
4N3V—BaiE from C. hiranonis DSM 13275 with 3-oxo-
D4,6-LC-CoA.
Docking simulations
Simulated substrate binding was performed with the
ASEDOCK module of MOE (Chemical Computing
Group, Montreal, Canada) to predict possible enzyme
substrate interactions. Models of the substrates 3-oxo-D4-
CDCA and 3-oxo-D4-CDC-CoA with expected protona-
tion states were generated using the Molecule Builder of
MOE and minimized using the Merck Molecular Force
Field 943. Search for potential substrate-binding pockets
were performed with the Site Finder module in MOE
using the induced-fit protocol, which allows rotatable
bonds during refinement of the docked molecules. The
top 30 hits were retained for further analysis for rele-
vance to catalysis.
RESULTS ANDDISCUSSION
Structure of BaiE, bile acid 7a-dehydratase
The final BaiE structures contained one (C. hiranonis
DSM13275 in space group P63 and C. hylemonae DSM
15053 in space group R32:h), three (C. scindens ATCC
35704 in space group P3121), and two (C. hiranonis
DSM13275 in space group R32:h) monomers in the
asymmetric unit with Rcryst/Rfree ranging between 15.1/
18.1 and 19.4/22.5, consistent with the respective resolu-
tions (Table I). The apo-structures were superimposed
using the Secondary Structure Matching (SSM) function
in COOT46 with pairwise rmsds ranging from 0.71 to
0.94 A˚ [Fig. 2(A)]. The major difference in the structures
is in the loop formed by residues 48–63, which is in a
significantly distinct conformation in each structure. The
electron density for the main chain and side chains is
well defined throughout, except for the last two C-
terminal residues of C. hiranonis DSM13275 and the last
three residues of C. hylemonae DSM15053. In addition
only Gly0 of the N-terminal expression and purification
tag had clearly interpretable electron density. All models
exhibited high-quality geometry with overall clash scores
greater than 99th percentile, and Ramachandran plot
with greater than 97% residues in favored regions as cal-
culated by MolProbity (v4.02b-509).47 The hexagonal
crystals of BaiE from C. hiranonis DSM13275 diffracted
to the highest resolution of 1.60 A˚.
The BaiE protomer is a single domain structure bear-
ing the characteristic twisted a1b barrel fold of the
NTF2-like protein superfamily.48 The secondary struc-
ture elements consist of three a-helices and six b-strands
[Fig. 2(B)]. The six b-strands that form the antiparallel
curved b-sheet are assembled on one side of the mono-
mer with a b2–b1–b6–b5–b4–b3 strand order. The three
a-helices flank the other side of the molecule and consist
of a 34-residue N-terminal helix, a1, and two a-helices
of 5 (a2) and 11 (a3) residues. Inspection of the main-
chain B-values indicate that residues 48–63 tend to
exhibit the highest values in all structures, suggesting
conformational flexibility [Fig. 2(B)]. A previously
reported homology model of BaiE from C. scindens VPI
1270815 superposes quite well with the crystal structures
with a backbone rmsd of 1.7 A˚ for the core a1b barrel
fold; however, as expected notable differences are
observed for residues 48–63.
Analytical size exclusion chromatography indicated
that all BaiE homologs reported here from trimers in
solution. BaiE also assembles as a trimer in the crystal
structure [Fig. 2(C)]. The asymmetric unit of the C. scin-
dens ATCC35704 BaiE crystal (space group P312)
Structure/Function Characterization of BaiE
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contains what is assumed to be the biological trimer.
Similar trimer assemblies can be generated in the other
crystal forms by crystallographic symmetry. The trimer
interface primarily involves a1 and strand-swapped inter-
actions between b6 and the C-terminal “strand” of the
neighboring monomer that stabilizes the bottom of the
trimer, with addition minor contributions from b3, b4.
Several key interactions are predicted to stabilize the
inter-protomer interactions including an octahedral six-
atom coordination of a divalent metal ion at the trimer
interface. The metal ion coordinates with three H86-Ne2
atoms from each symmetry-related subunit of the trimer
and three water molecules within 2.2 A˚. This divalent
ion–His coordination at the trimer interface is conserved
across all known structures of BaiE homologs. The pres-
ence of a divalent metal ion at the subunit interface has
been previously reported and considered to stabilize the
quaternary assembly.49 The anomalous difference Fourier
Table I
Data Collection and Refinement Statistics
Crystal
C. hiranonis
DSM 13275
C. scindens
ATCC 35704
C. hylemonae
DSM 15053
C. hiranonis
DSM 13275:3-oxo-
D4,6-LC-CoA
PDB id 4L8P 4LEH 4L8O 4N3V
Space group P63 P3121 R32:h R32:h
Unit cell lengths () a5 b5 58.9,
c5 91.3
a5 b5 109.3,
c5 118.3
a5 b5 53.0,
c5 428.6
a5 b5 84.3,
c5 311.8
Data collection
Beamline SSRL BL11-1 SSRL BL11-1 ALS 8.2.2 ALS 8.2.2
Data set SAD k1 MAD k2 MAD k3 MAD Native Native
Wavelength () 0.9795 0.9790 0.9795 0.9184 1.000 1.000
Resolution range () 29.5–1.60 29.6–2.90 29.6–2.98 29.5–2.90 28.6–2.20 47.4–1.89
Highest resolution shell () 1.64–1.60 2.98–2.90 3.06–2.98 2.98–2.90 2.32–2.20 1.94–1.89
No. of observations 172,513 137,535 63,001 68,430 77,498 362,382
No. of unique reflections 23,715 18,559 17,071 18,502 12,340 34,714
Completeness (%) 100 (100)a 99.9 (100) 99.9 (100) 99.9 (100) 99.3 (96.0) 99.9 (98.8)
Mean I/r(I) 11.1 (2.7)a 13.1 (1.8) 11.3 (2.0) 11.2 (1.8) 17.1 (2.7) 19.5 (2.5)
Rmerge on I (%)
b 9.5 (65.1)a 9.4 (112.3) 7.3 (61.8) 7.1 (73.0) 9.5 (55.7) 6.9 (88.5)
Rmeas on I (%)
c 10.2 (70.3)a 10.1 (120.6) 8.5 (72.3) 8.3 (85.5) 10.4 (61.9) 7.3 (95.3)
Rpim on I (%)
d 3.8 (26.4)a 3.7 (43.5) 4.4 (36.8) 4.2 (43.8) 4.1 (26.4) 2.2 (35.0)
Model and refinement statistics
Data used in refinement k1 MAD
No. of reflections (total)g 23,680 18,530 11,786 34,711
No. of reflections (test) 1,222 948 568 1,748
Cutoff criteria |F|>0 |F|>0 |F|>0 |F|>0
Rcryst (%)
e 15.1 17.7 19.4 18.8
Rfree (%)
f 18.1 21.7 22.5 21.8
Stereochemical parameters
Restraints (RMSD observed)
Bond lengths () 0.011 0.011 0.013 0.010
Bond angles (8) 1.49 1.49 1.32 1.38
MolProbity statistics
Ramachandran plot (%)h 97.6 (0) 98.0 (0) 98.8 (0) 99.4 (0)
Rotamer outliers (%) 2.1 0.7 0.0 2.1
All atom clashscore 1.4 1.0 0.4 3.2
Average isotropic B-value (2)i 24.8 (17.7) 96.3 (104.1) 35.2 (39.4) 35.8 (26.2)
ESU based on Rfree () 0.08 0.31 0.18 0.13
Protein residues/atoms 168/1366 501/4091 168/1335 334/2722
Non-protein entities 124 H2O, 1 Ni
1, 1 Na1,
2 PEG fragments
3 H2O, 8 SO42–,
1 Zn21
70 H2O, 1 SO42–,
1 Co21, 1 Na1,
4 ethylene glycol
189 H2O, 1 UNL,
2 Zn21, 2 Na1,
2 citric acid,
1 ethylene glycol,
1 PEG fragment
aValues in the parentheses are for the highest resolution shell.
bRmerge5RhklRi|Ii(hkl)2<I(hkl)>|/RhklRiIi(hkl).
cRmeas(redundancy-independent Rmerge)5Rhkl[Nhkl/(Nhkl2 1)]
1/2Ri|Ii(hkl)2<I(hkl)>|/RhklRiIi(hkl).
dRpim(precision-indicating Rmerge)5Rhkl[1/(Nhkl2 1)]
1/2Ri|Ii(hkl)2<I(hkl)>|/RhklRiIi(hkl).
eRcryst5RjjFobs|2 |Fcalcjj/R|Fobs|, where Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively.
fRfree5 as for Rcryst, but for 5% of the total reflections chosen at random and omitted from refinement.
gTypically, the number of unique reflections used in refinement is slightly less than the total number that were integrated and scaled. Reflections are excluded due to
systematic absences, negative intensities and rounding errors in the resolution limits and cell parameters.
hPercentage of residues in favored regions (Top8000) of Ramachandran plot (outliers in parenthesis).
iThis value represents the total B that includes TLS and residual B components. (Wilson plot B-value in parenthesis.).
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Figure 2
Structure of BaiE, bile acid 7a-dehydratase. (A) Secondary structure match (SSM) superposition of BaiE crystal structures from different organisms.
The main chain is colored gold, red, and blue, respectively, for C. hiranonis DSM13275, C. scindens ATCC35704 and C. hylemonae DSM15053. (B)
Characteristic twisted a1b barrel fold observed in BaiE. The secondary structure elements are colored according to Ca atomic B-value from blue
(lowest B-value: 20 A˚2) to red (highest B-value: 65 A˚2). The blue and red arrows, respectively, indicate the start and end of loop residues 48–63. (C)
Trimer assembly interface as observed in the crystal packing of BaiE, C. hiranonis DSM13275. Bound PEG molecules in the active site are indicated
as sticks. The three subunits of the trimer assembly are colored yellow, cyan and green. The six atom, (His)3-(H2O)3, octahedral coordination of the
Ni ion is depicted in the square panel. The view in the square panel corresponds to an 908 clockwise rotation of the view of the trimer assembly
in the primary figure around an axis perpendicular to the three-fold symmetry axis. The coordinate bonds are depicted as solid black lines. N, O,
and Ni atoms are colored blue, red, and brown, respectively. The carbon atoms of the protein chain are colored yellow, cyan, and green, respectively.
(D) SSM superposition of BaiE, C. hiranonis DSM13275 (gold), onto closest structural homologues as determined by DALI. The proteins used in
the superposition are two scytalone dehydrogenases (blue and cyan), LinA (magenta), an a1b barrel fold containing protein of unknown function
(PDB ID: 3ROB), and D5,3-ketosteroid isomerase (green). Two views between the figures are related by 908 anticlockwise rotation.
electron density maps suggests a mixture of Ni21 and
Zn21 ions in the trimer interface of BaiE, C. hiranonis
DSM13275. The Ni21 likely originated from the metal
affinity column used for purification, whereas Zn21 was
likely acquired during protein production. Neither of
these metal ions was present in the purification or crys-
tallization buffers. The peak intensity for Ni21 in the
structure is higher than Zn21 as it likely that some Zn
may have been exchanged with Ni during purification.
Based on these observations, we modeled the divalent
metal ion at the trimer interface in the final deposited
model of BaiE, C. hiranonis DSM13275 as Ni21. How-
ever, the divalent metal ion in the deposited model of
the homolog from C. scindens ATCC35704 is modeled as
Zn21 based on the X-ray fluorescence spectroscopy50
(data not shown). For the homolog from C. hylemonae
DSM15053, X-ray fluorescence data were inconclusive
and the divalent metal ion was modeled as Co21 since
the crystallization reagents contained CoCl2. Many inter-
subunit salt bridge interactions are also present at the
trimer interface (E4–R6, R6–E11, E21–K24, R32–E89,
and E150–R154) in addition to multiple hydrogen bond
interactions. Similar trimer interface salt bridges and
hydrogen bond interaction are also observed in related
structures from this protein family, such as scytalone
dehydratase (STD)48 and LinA.51 However, to our
knowledge, the metal–His interaction at the trimer inter-
face in BaiE is the first such interaction observed in this
family.
Analysis using DALI52 and FATCAT53 suggest BaiE is
similar to members of the NTF2 superfamily [Fig. 2(D)]
The closest structural homologs are STDs (DALI Z score:
16.8) and LinA (DALI Z score: 16.1). SSM superposition
by COOT achieved a core backbone rmsd of 1.5 A˚ >126
Ca atoms for comparison with STD54 (PDB ID: 3STD),
2.6 A˚ >110 Ca atoms with D5,3-ketosteroid isomerase55
(PDB ID: 1OPY), and 3.2 A˚ >117 Ca atoms with LinA
(PDB ID: 3A76). BaiE possesses less than 10% sequence
identity with the closest structurally related protein.
Substrate binding site
Analysis of both the monomer and the trimer BaiE
structure with the Site Finder module of the Molecular
Operating Environment package (MOE; Chemical Com-
puting Group, Montreal, Canada) indicates that the
substrate-binding pocket [Fig. 3(A)] is the largest surface
cavity with a volume of 451 A˚3 as determined by
CASTp56 [Fig. 3(B)]. Secondary structure elements a1,
b1, and b2 form the mouth, while a3, b3, b4, b5, and
b6 form the floor of the binding pocket. Y30 (a1), D35
(a1), and H83 (b3) that were shown to participate in
catalysis by site-directed mutagenesis (see below) are
indeed located in the substrate binding pocket. Crystal
structures of the four BaiE homologs revealed the D35
and H83 side chains interact within a distance of 2.8 A˚
[Fig. 3(C)]. However, no interaction is observed between
Y30 and the other two catalytic residues. In BaiE, C. hir-
anonis DSM13275, Y30 interacts (2.8 A˚) with an oxygen
atom of a PEG molecule bound in the active site. D106
(b4) and R146 (b6) in the substrate binding pocket are
conserved across all the BaiE homologs and interact via a
salt bridge (2.8 A˚) that is conserved in all apo-structures
of BaiE homologs.
Predicted enzyme:substrate interaction by
simulated docking experiments
Docking experiments of the substrate 3-oxo-D4-CDCA
into the BaiE binding pocket with the ASEDock module
of MOE identified a potentially productive binding
mode that is consistent with our site-directed mutagene-
sis experiments [Fig. 4(A)]. In this binding mode, the
C3-oxo and C7-hydroxyl groups are located 3.1 and 3.6
A˚ from Y30-Oh and H83-NE2 atoms, respectively.
H83—NE2 is 2.7 A˚ from the 6a-hydrogen compared
with 4.5 A˚ from the 6b-hydrogen. The H83–imidazole is
therefore positioned to abstract the 6a hydrogen and
protonate the leaving C7-hydroxy group complying with
a cis-elimination of water (6aH, 7a-OH). However, pre-
vious studies with triply tritiated and singly C14 labeled
cholic acid (6a, 6b, 8b-H3, 24-C14) detected a diaxial trans-
elimination of water (6bH, 7a-OH).57 Further experiments
with purified BaiE utilizing 3-oxo-D4 derivatives of both a-
and b-muricholic acid (3a,6b,7a-trihydroxy-5b-cholanoic
acid) and hyocholic acid (3a,6a,7a-trihydroxy-5b-cholanoic
acid) should help resolve the stereochemistry of the 7a-
hydroxyl elimination reaction.
Computational calculations with the substrate 3-oxo-
D4-CDC-CoA predicted probable binding interactions of
the CoA moiety in addition to predicting a similar pro-
ductive binding mode of the bile acid moiety [Fig. 4(B)].
The calculation predicted a twisted conformation of CoA
where the adenine moiety is involved in a p–p stacking
interaction with Y115. In such a conformation, a signifi-
cant portion of both the pantetheine and AMP moieties
of CoA would be exposed to the bulk solvent without
any direct interaction with the protein. This scenario has
previously been observed in crystal structures of thiolase
where the AMP portion projects out of the substrate
binding pocket and interacts only with surface resi-
dues.58,59 Thus, it seems that only the bile acid moiety
binds in the active site pocket with no space to accom-
modate the CoA moiety. The CoA moiety likely projects
out in the solvent possibly interacting with surface resi-
dues. This topology is supported by the co-crystal struc-
ture of BaiE with 3-oxo-D4,6-LC-CoA where the bile acid
moiety is observed to bind in the active site and the
CoA moiety extends into the solvent exhibiting poor
electron density, as described below.
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Crystal structure of BaiE3-oxo-D4,6-
lithocholyl CoA
The co-crystal structure of BaiE with 3-oxo-D4,6-LC-
CoA shows a novel extended pocket that was not pre-
dicted by the simulated docking experiments. This
extended pocket is generated by the substrate binding
sites of two protomers that originate from two different
trimer assemblies related by two-fold non-
crystallographic symmetry (NCS). A key loop comprising
residues 48–63 in the substrate binding site of each pro-
tomer forms the extended pocket [black and blue circles
in Fig. 5(A)]. Interestingly, this loop in the co-crystal
structure protrudes into the substrate binding site of the
protomer related by NCS. This extended conformation is
stabilized by hydrogen bond interaction with several resi-
dues from the NCS related protomer [Fig. 5(B)]. Impor-
tantly, the D56 carboxylate hydrogen bonds with the
H83 imidazole in the NCS related protomer, which is
one of the three catalytic residues. An additional set of
hydrogen bonds is observed with loop residues T52, Y54,
S55, and G57, and their respective partners in the bind-
ing site of the two-fold related protomer: K114 (with
T52), Y115 (with Y54), H151 (with Y54), R146 (with
S55), E149 (with S55), and Y70 (with G57).
Although the resolution (1.9 A˚) of the structure is rea-
sonably high, the electron density of the ligand is rela-
tively poor compared with the protein. Analysis of the
electron density map suggests partial occupancy and a
dual conformation of the substrate across the NCS two-
fold axis [Fig. 5(C)]. Attempts at modeling the entire
product indicated that the ligand extends from the
Figure 3
Substrate binding site of BaiE, bile acid 7a-dehydratase. (A) Location of the active site of one protomer with respect to the trimer assembly. The
protomers of the trimer are colored gold, blue, and green. (B) Cavities in the monomer structure of BaiE. Inner surface of the cavities are colored
gray and the outer surface are colored black. The substrate binding site is indicated by the black arrow. (C) Key interaction involving residues of
the substrate binding site with PEG and water molecules in BaiE, C. hiranonis DSM13275. 2Fo-Fc electron density map colored cyan contoured at
1.0 sigma. Dashed black lines are hydrogen bond interactions with distances in A˚ between the interacting atoms. Carbon atoms of protein residues
and PEG molecule are colored gold and green, respectively. O, N, P, and S atoms are in red, blue, and orange, respectively.
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binding site of one protomer to the binding site of the
other protomer with the CoA moiety presumably extend-
ing into the solvent. Therefore, the bile acid product was
modeled in two different orientations.
As shown in Figure 5(C) in the top and bottom pan-
els, the bile acid moiety is modeled, respectively, into
each half of the electron density maps. Furthermore, the
ligand comprising only the bile acid and pantetheine
moieties fits well into the unbiased mFo–DFc electron
density at relatively low contour level, 11.8 rmsd (0.085
e2/A˚3) in either orientation. In addition, in either orien-
tation, the C3-oxo of the bile acid is within 2.7 A˚ from
the side-chain hydroxyl of the active site Y30 within the
same protomer. Hence, in the final deposited structure,
the bile acid product was modeled in two overlapping
orientations in each active site.
The 2mFo–DFc electron density map generated after
addition of the entire product in either orientation
revealed continuous electron density features over bile
acid moiety and part of the pantetheine moiety at con-
tour levels ranging from 10.8 rmsd (0.21 e2/A˚3) to 11.0
rmsd (0.26 e2/A˚3). However, the AMP, the dimethyl
group, and the pyrophosphate linkage regions do not
have electron density coverage. Although an additional
electron density blob is observed adjacent to the bile acid
moiety, attempts at modeling the AMP moiety into this
blob shows that the shape is not consistent with that
assignment. Therefore, due to difficulty in unequivocal
assignment of the ligand arising from partial occupancy
and dual binding mode across the NCS two-fold, the
ligand is modeled as an unknown ligand (UNL) with a
dual conformation. In the UNL, the AMP moiety, pyro-
phosphate linkage and dimethyl group are omitted.
Detection of product formation by 1H-NMR
A time series of proton NMR spectra were collected to
directly monitor the enzymatic removal of the C7a-
hydroxy group and the generation of 3-oxo-D4,6 bile acid
intermediate by BaiE. These data provided an unambiguous
analytical probe to confirm the generated product. Selected
regions of proton spectra for the BaiE mediated conversion
of 3-oxo-D4-CDC-CoA to 3-oxo-D4,6-LC-CoA are shown in
Figure 6. Aromatic and methyl regions (left and right pan-
els, respectively) of the spectra acquired at different time
points after the addition of enzyme are shown. During the
reaction, the intensities of the substrate peaks decrease with
a concomitant appearance of a new set of peaks, as readily
observed in Figure 6, where the intensity of selected sub-
strate peaks at 5.81, 1.17, and 0.59 ppm (marked with
dashed lines) decrease as the reaction proceeds. This inten-
sity loss is associated with the appearance of a new set of
peaks at 5.71, 1.05, 0.63 ppm (marked with dotted lines)
that increase in intensity. The reaction appeared to be
almost complete after 2 hours with only minor evidence of
substrate peaks remaining. The chemical shifts of the new
peaks perfectly match a control spectrum acquired of 3-
oxo-D4,6-LC-CoA in the same buffer (compound B in Fig.
6) and is observed for all peaks in the spectra and not iso-
lated only to the regions displayed. Close examination of
Figure 4
Predicted enzyme:substrate interactions. (A) Probable productive binding mode of 3-oxo-D4-Chenodeoxycholate (3-oxo-D4-CDCA). Blue dashed
lines and distances are predicted interaction of His83-Ne2 atom with C7-OH and C6 atoms and Y30-OH group with C3-oxo atom of 3-oxo-D4-
CDCA. The 6a-H closest to H83-Ne2 atom is in magenta and 6b-H away from H83–Ne2 atom is in brown. (B) Predicted stacking interaction
involving the adenine group of the Coenzyme (CoA) moiety of 3-oxo-D4-Chenodeoxycholyl CoA (3-oxo-D4-CDC-CoA) with Y115. The key inter-
action of the bile acid moiety of the docked CoA-bile acid ester with the active site residues is similar to what is predicted in (A). Carbon atoms of
protein residues and product molecule are in gold and green, respectively. H, O, N, P, and S atoms are in gray, red, blue, orange, and olive,
respectively.
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the aromatic region in Figure 6 shows the appearance of
two new doublets during the reaction as expected for the
methene groups generated by removal of the 7a-hydroxyl
group. One doublet is isolated and clearly observed at 6.23
ppm (marked with a dotted line) and the second is
observed as part of the overlapped peak at approximately
6.14 ppm. These data confirm that BaiE is converting 3-
oxo-D4-CDC-CoA to the expected product 3-oxo-D4,6-LC-
CoA.
Site-directed mutagenesis
Mutation of predicted key catalytic and substrate bind-
ing residues of BaiE from C. scindens VPI 12708 provide
important insights into their involvement in substrate
turnover and binding (Table II). Y30F, D35N, and H83N
mutations completely abolished substrate turnover indi-
cating involvement of these residues in catalysis. How-
ever, increased substrate binding is observed for mutants
Y30F (5.6-fold) and D35N (3.0-fold) compared with
wild type, but no substrate binding is found for the
H83N mutant. Y30 of BaiE is equivalent to Y14 in 3-
oxo-D5-ketosteroid isomerase (KSI) and is predicted to
participate as a general acid protonating or forming a
low barrier hydrogen bond (LBHB) with the dienolate
intermediate during the isomerization reaction.55 Y126
may stabilize the negative charge on the dienolate inter-
mediate as confirmed by 98% reduced catalytic activity
observed in Y126F. In KSI, D99 participates in catalysis
in a similar manner. H83 and D35 are equivalent to the
Figure 5
Binding of product, 3-oxo-D4,6-Lithocholyl-CoA (3-oxo-D4,6-LC-CoA, in BaiE, C. hiranonis DSM13275. (A) The extended binding pocket and bind-
ing of 3-oxo-D4,6-LC-CoA, in BaiE, C. hiranonis DSM13275. Main chain of protomers arising from different trimer assemblies is in gold and green,
respectively. The loop formed by residues 48–63 is bordered by black and blue ellipses in the gold and green monomers, respectively. The black arrow
indicates the location of the C3-oxo atom. (B) Key inter-protomer interactions involved in generating the extended binding pocket. Numbers indi-
cate distances in A˚. (C) Unbiased mFo-DFc electron density map of 3-oxo-D4,6-LC-CoA contoured at 11.8 r (0.085 e2/A˚3). For clarity, both orien-
tations of the ligand are shown separately to illustrate how the model fits the density. A model with the two orientations together at partial
occupancy fits the density better than either orientation on its own. The pyrophosphate and AMP moiety of the product is not shown. The density
fit for those regions is not as good (see text). Product 3-oxo-D4,6-LC-CoA in panels A and B is depicted as spheres.
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H85–D31 catalytic dyad in STD that is predicted to par-
ticipate as a general base.60 Mutation of the H85–D31
pair in STD also impaired catalysis. Site-directed muta-
genesis also revealed D106 and R146 in the substrate
binding pocket as essential for catalysis. In all apo-
structures of BaiE, side chains of D106 and R146 interact
via salt bridge at a distance of 2.9 A˚. Disruption of this
salt bridge by mutation to Asn and Gln at positions 106
and 146, respectively, abolished catalysis.
Site-directed mutagenesis of one residue of the confor-
mationally flexible loop comprising residues 48–63 indi-
cates the importance of this loop in catalysis. A Y54F
mutation reduced enzyme activity by 74% compared
with wild type, whereas Y54A abolished enzyme activity.
This result suggests Y54 is probably important for main-
taining the shape of the active site and recognition of the
substrate. In the 3-oxo-D4,6-LC-CoA co-crystal structure
of BaiE, Y54 seems to be involved in key stacking inter-
actions with Y115 and H151 of the NCS two-fold related
monomer at the pocket interface.
Steady state kinetic studies
Steady-state kinetics (Table III) analysis was performed
by continuous UV assay monitoring of the formation of
product utilizing an extinction coefficient, e2975 0.0188/
mM/cm, measured at pH 7.3. All four homologs of BaiE
revealed robust turnover of CoA-esters of bile acid and
free bile acid substrates. The substrate affinity, KM, for
Figure 6
In vitro generation of 3-oxo-D4,6- lithocholyl-Coenzyme A from 3-oxo-
D4-Chenodeoxycholyl CoA(3-oxo-D4-CDC-CoA) using purified BaiE
from C. hiranonis DSM13275 as monitored by 1H-NMR. A reaction
mixture of 100 mM 3-oxo-D4-CDC-CoA (3-oxo-D4,6-LC-CoA) and
0.001 mM BaiE was prepared in 20 mM HEPES pH 7.4 and incubated
at 300K. Selected regions from one-dimensional 1H-NMR spectra that
were acquired at the indicated times after mixing and temperature
equilibration (bottom four spectra) are displayed. Reference spectra of
3-oxo-D4-CDC-CoA and 3-oxo-D4,6-LC-CoA acquired in the same
buffer are shown at the top labeled A and B, respectively. Some repre-
sentative peaks associated with 3-oxo-D4-CDC-CoA and 3-oxo-D4,6-LC-
CoA are marked with dashed and dotted lines, respectively. The intensity
of peaks associated with the substrate decrease with a concomitant
increase in product peaks during the reaction. The spectrum of the
product matches perfectly the spectra of 3-oxo-D4,6-LC-CoA. Examina-
tion of the amide region of the spectra (right hand panel) shows the
appearance of two new peaks during the reaction and is associated with
removal of the 7a-hydroxyl group and the generation of methene
groups.
Table II
Relative Activity and Substrate Binding of Several Site-Directed Mutants
of BaiE, C. scindens VPI12708
BaiE
mutation
Relative
activitya
Substrate
binding
(%)
Wild type 111 1.5
Y30F 2 8.4
D35N 2 4.6
Y54A 2 2.8
Y54F 11 4.1
H83N 2 <0.1
D106N 2 2.3
Y126F 1 10.7
R146Q 2 10.4
aDash denotes activity assays where <0.1% of substrate converted to product.
Table III
Steady State Kinetic Parameters of Different Homologs of BaiE from
Key Clostridium sp. Associated with Secondary Bile Acid Synthesisa
Homolog
Kinetic
parameters
Substrates
3-oxo-D4-CDCA 3-oxo-D4-CDC-CoA
BaiE_15053 kcat (sec
21) 18.6 (0.6) 12.6 (0.6)
KM (mM) 21.0 (2.0) 11.4 (1.9)
kcat/KM
(mM21 sec21)
0.9 1.1
BaiE_13275 kcat (sec
21) 4.4 (0.1) 22.2 (2.6)
KM (mM) 25.0 (1.8) 208.0 (40.0)
kcat/KM
(mM21 sec21)
0.2 0.1
BaiE_35704 kcat (sec
21) 18.0 (0.9) 15.0 (0.2)
KM (mM) 11.0 (1.9) 1.2 (0.2)
kcat/KM
(mM21 sec21)
1.6 12.5
BaiE_12708 kcat (sec
21) 24.0 (1.4) 98.0 (2.7)
KM (mM) 9.9 (2.1) 4.0 (0.56)
kcat/KM
(mM21 sec21)
2.4 24.5
aSteady state kinetic parameters were analyzed at substrate concentrations ranging
beyond and below the respective KM values. Reaction was monitored by the for-
mation of product 3-oxo-D4,6-lithocholic acid and 3-oxo-D4,6-lithocholyl-CoA for
respective substrates at wavelength 297 nm. Values in parentheses indicate stand-
ard error.
BaiE_15053: BaiE from Clostridium hylemonae DSM15053.
BaiE_13275: BaiE from Clostridium hiranonis DSM13275.
BaiE_35704: BaiE from Clostridium scindens ATCC35704.
BaiE_12708: BaiE from Clostridium scindens VPI12708.
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the free bile acid substrate, 3-oxo-D4-CDCA is of compa-
rable magnitude across all the four homologs. The KM
values of the CoA-bile acid ester 3-oxo-D4-CDC-CoA are
also of comparable magnitude across all homologs except
for BaiE C. hiranonis DSM13275 where the KM is 208
mM, which is at most two orders of magnitude higher
than the others. Furthermore, the turnover rate constants
(kcat) of both substrates are comparable in all three
homologs except C. scindens VPI12708, where the kcat is
at most 7.7 times higher. Both BaiE homologs from C.
scindens ATCC35704 and VPI12708 respectively exhibited
higher substrate specificity (kcat/KM) toward the CoA-
ester substrate by an order of a magnitude. In contrast,
both BaiE homologs from C. hylemonae DSM15053 and
C. hiranonis DSM13275, respectively, exhibited kcat/KM
values of equal magnitude toward both substrates. Over-
all, higher kcat/KM values are attained for the BaiE homo-
logs from C. scindens strains in comparison to the
homologs from the other two strains.
Mechanism of catalysis
Based on the active site architecture as observed in the
crystal structures and the site-directed mutagenesis study,
we propose the following mechanism of catalysis by BaiE
(Fig. 7). Y30 acts as a general acid (assisted by Y126)
facilitating delocalization of the p-electrons across atoms
C3, C4, C5, and C6. Based on the 3-oxo-D4-CDC-CoA
co-crystal structure, the terminal hydroxyl group of Y30
could potentially protonate the oxyanion generated on
C3-oxo group to stabilize the negative charge. This
would result in an electron shift destabilizing the C6-
6aH bond. H83 is then positioned to abstract the 6aH
atom and protonate the leaving C7a-hydroxy group. D35
maintains the pKa value of the H83-imidazole group for
executing the deprotonation and ensuing protonation
reaction with the subsequent release of a water molecule.
CONCLUSION
Combined structural and biochemical analysis of BaiE
provides key insights into substrate binding and turn-
over. The 1.9 A˚ resolution 3-oxo-D4,6-LC-CoA co- crystal
structure of BaiE revealed an extended pocket between
monomers from different trimer assemblies, although the
biological relevance of this is unclear. Substrate and co-
factor induced oligomerization is previously noted to be
involved in catalysis of varied enzyme classes.58–61
Moreover, using analytical size exclusion chromatography
(AnSEC) on the batch of BaiE C. hiranonis DSM13275
that yielded the co-crystal structure, we were able to
detect higher-order species of the protein in presence of
both bile acid substrates and products (data not shown).
Although we have not been able to directly correlate
these higher-order species with enzymatic activity, our
data suggest possible substrate and ligand-induced oligo-
merization where the substrate/product binds in the
extended pocket created between trimers by conforma-
tional flexibility of residues 48–63, as observed in the
crystal structure. Comparison of the apo-structures
across varied homologs reveals a dramatically different
conformation of loop 48–63. The conformational flexibil-
ity of this loop at the substrate binding site may be
essential for substrate binding. Site-directed mutagenesis
studies with Y54F and Y54A mutants of BaiE from C.
hylemonae VPI12708 revealed respective impaired sub-
strate binding and catalytic activity, suggesting the
importance of this loop in catalysis.
The biochemical characterization reported herein pro-
vides key insights into the mechanism of catalysis of the
enzyme, and also sheds new light onto the pathway.
Figure 7
Proposed mechanism of catalysis by BaiE highlighting the role of catalytically important residues in elimination of the 7a-hydroxy group through
release of a water molecule.
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Steady-state kinetic studies reveal that all homologues of
BaiE efficiently turnover both 3-oxo-D4-bile acid and
CoA-3-oxo-D4-bile acid esters. This result is in stark con-
trast to our earlier reported characterization of BaiA
enzymes that exhibited substantially high substrate speci-
ficity toward CoA-bile acid esters.22 The substrate selec-
tivity of bile acids is substantially lower for BaiA
enzymes. It is unclear at what point in the pathway the
CoA moiety is released. Since the BaiE homologues turn-
over bile acid and CoA-bile acid ester with comparable
efficiency, it seems likely that a dual possibility exists in
the pathway where the CoA moiety can be removed
either before or after elimination of the C7-hydroxy
group. Strains of human bile acid 7 a/b-dehydroxylating
bacteria do not 7-dehydroxylate muricholic acids. This
could be due to lack of uptake of muricholic acids
(transporter specificity), or ligation to CoA, oxidation of
3-a-hydroxy group, or introduction of a C@C double
bond (C4AC5). In other words, the initial reactions in
the pathway may not allow the 3-oxo-delata 4–6-b, 7a-
dihydroxy-cholenoic acid to be formed. Therefore, it is
unclear if the bile acid 7a-dehydratase would recognize
this as a substrate. However, muricholic acids are not
found in humans and we have been unable to isolate bile
acid 7-dehydroxylating bacteria from mice using the
same techniques used to successfully isolate these bacteria
from human feces. Furthermore, the DNA probes used
to detect genes in human isolates give negative results
using mice fecal samples. Evaluating the substrate speci-
ficity of yet-to-be identified enzymes in the reductive
arm of the pathway for CoA-bile acid esters and bile acid
is required to understand the role of CoA in the path-
way. Site-directed mutagenesis with the homologue from
C. scindens VPI12708 provides key insights into substrate
binding and catalysis. Y30, D35, and H83, which are
conserved in the family, were confirmed as active site res-
idues participating in catalysis. In addition, Y54, D106,
and R146 in the active site are crucial in catalysis,
although they do not directly participate in the catalytic
chemistry.
This study has therefore provided key insights into the
mechanism of C7a-hydroxy group removal from the bile
acid moiety catalyzed by BaiE. Previous studies alluded
to the possibility of trans-elimination as the stereochemi-
cal route of the reaction.57 However, from the crystal
structures and simulated docking study, cis-elimination is
a likely possibility. Further experiments involving 3-oxo-
D4 intermediate of a-muricholic acid may ascertain the
stereochemical route.
The reaction catalyzed by BaiE is pivotal in the path-
way as it catalyzes the only irreversible reaction whereby
the intermediate is channeled onto the reductive arm
generating the secondary bile acids. Hence, the biochemi-
cal and the structural characterization of this enzyme
will be crucial in generating key modulators controlling
the level of secondary bile acids in disease.
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